A Phase II study of docetaxel in patients with liver metastases from breast cancer

scientific article published on 01 May 2000

A Phase II study of docetaxel in patients with liver metastases from breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1023/A:1008383707159
P698PubMed publication ID10907946

P50authorAnthony HowellQ37828919
P2093author name stringR E Coleman
D W Miles
S P Eggleton
S J Maling
P2860cites workProspective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study GroupQ33328841
Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effectsQ36790555
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patientsQ40626897
Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancerQ41060508
Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.Q52131305
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.Q54071888
P433issue5
P921main subjectdocetaxelQ420436
P304page(s)541-546
P577publication date2000-05-01
P1433published inAnnals of OncologyQ326122
P1476titlePhase II study of docetaxel in patients with liver metastases from breast cancer. UK study group
P478volume11

Reverse relations

cites work (P2860)
Q73733125A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases
Q35577441Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials
Q41986750Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis
Q40420500Docetaxel shows radiosensitization in human hepatocellular carcinoma cells
Q39329443Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method
Q37957744Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials.

Search more.